Article: The OM-85 bacterial lysate: a new tool against SARS-CoV-2?
Multidisciplinary respiratory medicine
2023 Volume 18, Page(s) 906
Abstract: The emergence of SARS-CoV-2, a novel coronavirus, caused the global Coronavirus disease of 2019 (COVID-19) pandemic. Because SARS-CoV-2 mutates rapidly, vaccines that induce immune responses against viral components critical for target cell infection ... ...
Abstract | The emergence of SARS-CoV-2, a novel coronavirus, caused the global Coronavirus disease of 2019 (COVID-19) pandemic. Because SARS-CoV-2 mutates rapidly, vaccines that induce immune responses against viral components critical for target cell infection strongly mitigate but do not abrogate viral spread, and disease rates remain high worldwide. Complementary treatments are therefore needed to reduce the frequency and/or severity of SARS-CoV-2 infections. OM-85, a standardized lysate of 21 bacterial strains often found in the human airways, has immuno-modulatory properties and is widely used empirically in Europe, South America and Asia for the prophylaxis of recurrent upper airway infections in adults and children, with excellent safety profiles. |
---|---|
Language | English |
Publishing date | 2023-01-26 |
Publishing country | Italy |
Document type | Journal Article |
ZDB-ID | 2677839-7 |
ISSN | 2049-6958 ; 1828-695X |
ISSN (online) | 2049-6958 |
ISSN | 1828-695X |
DOI | 10.4081/mrm.2023.906 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.